Invesco
PRAX icon

Invesco’s Praxis Precision Medicines PRAX Stock Holding History

Invesco’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$180M Buy
537,548
+476,151
+776% +$151M 0.01% 739
2026
Q1 		$19.8M Sell
61,397
-15,691
-20% -$4.85M ﹤0.01% 1462
2025
Q4 		$22.7M Buy
77,088
+56,220
+269% +$10.5M ﹤0.01% 1401
2025
Q3 		$1.11M Buy
20,868
+4,929
+31% +$239K ﹤0.01% 2879
2025
Q2 		$670K Buy
15,939
+4,261
+36% +$162K ﹤0.01% 3040
2025
Q1 		$442K Sell
11,678
-75,305
-87% -$4.7M ﹤0.01% 3195
2024
Q4 		$6.69M Sell
86,983
-20,730
-19% -$1.5M ﹤0.01% 2090
2024
Q3 		$6.2M Buy
107,713
+98,901
+1,122% +$5.34M ﹤0.01% 2102
2024
Q2 		$364K Sell
8,812
-86,369
-91% -$4.08M ﹤0.01% 3419
2024
Q1 		$5.81M Buy
+95,181
New +$4.27M ﹤0.01% 2132
2023
Q2 		– Sell
-700
Closed -$8.5K – 3924
2023
Q1 		$8.5K Sell
700
-9
-1% -$380 ﹤0.01% 3843
2022
Q4 		$25.3K Sell
709
-151
-18% -$4.71K ﹤0.01% 3960
2022
Q3 		$29K Sell
860
-6
-0.7% -$299 ﹤0.01% 3955
2022
Q2 		$32K Buy
866
+33
+4% +$3.52K ﹤0.01% 4017
2022
Q1 		$127K Buy
833
+27
+3% +$5.55K ﹤0.01% 3842
2021
Q4 		$239K Buy
806
+79
+11% +$23.2K ﹤0.01% 3713
2021
Q3 		$201K Buy
+727
New +$197K ﹤0.01% 3806

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Invesco's PRAX Position: Q2 2026 in Review

Invesco increased its Praxis Precision Medicines (PRAX) stake by 776% in Q2 2026, buying an estimated $151M and bringing the position to 537,548 shares worth $180M. The position accounts for 0.01% of the portfolio, ranked #739.

Invesco first reported a position in PRAX in Q3 2021 and has held it in 17 quarters since. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Invesco held 537,548 shares of Praxis Precision Medicines worth $180M as of Q2 2026.
  • Invesco bought 476,151 Praxis Precision Medicines shares in Q2 2026, an estimated $151M.
  • Praxis Precision Medicines made up 0.01% of Invesco's portfolio in Q2 2026, its #739 holding.
  • Invesco first reported a position in Praxis Precision Medicines in Q3 2021 and has held it in 17 quarters since.
  • 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.